0001594062-19-000037.txt : 20190521 0001594062-19-000037.hdr.sgml : 20190521 20190521155339 ACCESSION NUMBER: 0001594062-19-000037 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190521 DATE AS OF CHANGE: 20190521 EFFECTIVENESS DATE: 20190521 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Qrons Inc. CENTRAL INDEX KEY: 0001689084 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 813623646 STATE OF INCORPORATION: WY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-340093 FILM NUMBER: 19842304 BUSINESS ADDRESS: STREET 1: 50 BATTERY PLACE, #7T CITY: NEW YORK STATE: NY ZIP: 10280 BUSINESS PHONE: 212-945-2080 MAIL ADDRESS: STREET 1: 50 BATTERY PLACE, #7T CITY: NEW YORK STATE: NY ZIP: 10280 FORMER COMPANY: FORMER CONFORMED NAME: BIOLABMART INC. DATE OF NAME CHANGE: 20161102 D 1 primary_doc.xml X0708 D LIVE 0001689084 Qrons Inc. 50 BATTERY PLACE, #7T NEW YORK NY NEW YORK 10280 212-945-2080 WYOMING BIOLABMART INC. Corporation true 2016 Jonah Meer 50 Battery Place, # 7T New York NY NEW YORK 10280 Executive Officer Director Ido Merfeld 153 Hagilboa Street Nirit L3 ISRAEL 44805 Executive Officer Director Biotechnology Decline to Disclose 06b false true false true true false 10000 Network 1 Financial Services Inc. 13577 None None 2 Bridge Avenue. Suite 241 Red Bank NJ NEW JERSEY 07701 CT CONNECTICUT FL FLORIDA NJ NEW JERSEY NY NEW YORK false 1000000 0 1000000 false 0 100000 true 0 Sales commissions is 10% of the gross proceeds sold. Placement Agent will also receive a four-year warrant to purchase 10% of the shares sold at an exercise price of $2.50 per share and a 3% cash fee of the proceeds from the exercise of the warrants sold. 0 false Qrons Inc. /s/Jonah Meer Jonah Meer Chief Executive Officer 2019-05-21